Bergen Brunswig Corp.: The Orange supplier of...
Bergen Brunswig Corp.: The Orange supplier of pharmaceuticals and medical-surgical products said net income for the first fiscal quarter rose 17% to $21.3 million, or 42 cents a share, from $18.2 million, or 36 cents a share, a year ago. Revenue for the quarter ended Dec. 31 advanced 14% to $3.2 billion from $2.8 billion.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
